Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 446 | 91 | 106 | 47 |
| Cost of Goods | 2,197 | 481 | 18 | 11 |
| Gross Profit | -1,752 | -390 | 88 | 36 |
| Operating Expenses | 9,810 | 5,765 | 1,667 | 739 |
| Operating Income | -11,365 | -5,674 | -1,562 | -693 |
| Interest Expense | 0 | 0 | 82 | 119 |
| Other Income | 96 | 241 | -8 | 5 |
| Pre-tax Income | -11,268 | -5,433 | -1,652 | -807 |
| Net Income Continuous | -11,268 | -5,433 | -1,652 | -807 |
| Net Income | $-11,268 | $-5,433 | $-1,652 | $-807 |
| EPS Basic Total Ops | -217.52 | -397.54 | -82.51 | -108.76 |
| EPS Basic Continuous Ops | -218.99 | -134.00 | -81.32 | -107.26 |
| EPS Diluted Total Ops | -217.52 | -397.54 | -82.51 | -108.76 |
| EPS Diluted Continuous Ops | -218.99 | -134.00 | -81.32 | -107.26 |
| EBITDA(a) | $-10,529 | $-5,574 | $-1,546 | $-676 |